AIM:NYSEAMERICAN
AIM ImmunoTech Inc
$0.22
arrow_downward
-3.83%(-0.0087) 1D
Sep 11, 9:30:10 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AIM...
Open
$0.22
High
$0.22
Low
$0.22
Mkt. cap
6.73M
Avg. vol.
8.71M
Volume
1.44M
52-wk high
$2.98
52-wk low
$0.19
EPS
-$3.93
Beta
1.19
Shares outstanding
30.44M
No. of employees
20
Open
$0.22
High
$0.22
Low
$0.22
Mkt. cap
6.73M
Avg. vol.
8.71M
Volume
1.44M
52-wk high
$2.98
52-wk low
$0.19
EPS
-$3.93
Beta
1.19
Shares outstanding
30.44M
No. of employees
20
News stories
From web sources and news partners
TipRanks
·
16 hours ago
AIM ImmunoTech Reduces Debt via Equity Exchange Agreements
TradingView
·
16 hours ago
AIM ImmunoTech Converts ~$450,000 of Note Into 1.92M Shares in Exchanges With Streeterville
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websiteaimimmuno.com